Marcelo Calil Instituto Brasileiro de Controle do Câncer

Slides:



Advertisements
Similar presentations
Mammary ductal carcinoma
Advertisements

Breast Cancer in Pregnancy
AJCC TNM Staging 7th Edition Breast Case #3
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
Breast Cancer Clinical Cases Daniel A. Nikcevich, MD, PhD SMDC Cancer Center April 20, 2009.
Experience and Outcomes with Hypofractionated Concurrent Chemoradiation for Stage III NSCLC at NCCC Gregory Webb Medical Student.
Clinical features and outcome in ovarian sarcomas: Analysis of a single-institution experience A López Pousa, X Gonzàlez Farré, MJ. Quintana, S Bagué,
Comparing the Positive Effect of Vitamin E and Flouxetine in the Treatment of Hot Flashes in Breast Cancer Patients. Comparing the Positive Effect of.
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
Breast Cancer Awareness Marissa Gregg. What is Breast Cancer?  Breast Cancer forms in the breast  It is a tumor in the breast  Breast cancer is the.
Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.
The Role of Ultrasound of the Regional Nodal Basins in Staging Patients with Triple Negative Breast Cancer: Implications for Local-Regional Treatment Simona.
Management of DCIS KWH Experience Dr. Carmen Ho.
2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.
TEMPLATE DESIGN © ONCOLOGICAL REFERRAL PATTERNS OF GYNAECOLOGICAL CANCER PATIENTS OVER 2010 – 2011 THE NEED FOR GYNAECOLOGIC.
HER2 POSITIVE BREAST CARCINOMA IN THE PRE AND POST ADJUVANT ANTI-HER-2 THERAPY ERA: A SINGLE ACADEMIC INSTITUTION EXPERIENCE IN THE SETTING OUTSIDE OF.
Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience Curzon M, Curzon C,
Neoadjuvant SystemicTreatment Strategies for Breast Cancer Donald W. Northfelt, MD, FACP Professor of Medicine Mayo Clinic College of Medicine Associate.
Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, MD 1, Bruce.
بسم الله الرحمن الرحيم. Adult Hodgkin’s Lymphoma in the Eastern Part of Libya Dr. M.Mangoush, R. Nafo, S.Kardah, M.Letaiwish, S.Kardah, F.Bodabous, S.Ebkhatra.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
HEAPHY 1 & 2 CASE RACE 1 – DIAG Yvonne CLARKE Sat 31 st Aug 2013 Session 3 / CR1-4 13:16 – 13:20 WELLINGTON ABSTRACT Following a woman’s pathway from her.
Pathology.
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer Gunter von Minckwitz, Jens Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann Journal.
Radiological-histological size correlation in triple-negative breast cancer (TNBC) Abstract # 8254 C Thibault 1, M Gosset 2, F Chamming’s 3, M-A Lefrere-Belda.
ADVERSE PROGNOSTIC FACTORS IMPACTING SURVIVAL IN RESECTED INVASIVE, MUCINOUS CYSTADENOCARCINOMAS OF THE PANCREAS Stephen J. Ko 1, Michele M. Corsini 2,
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal- cell carcinoma after radical nephrectomy: phase III,
R2 김형오 / Pf. 김시영.  Recent results  Presence of extensive lymphocytic infiltration in early stage breast cancer  Good prognosis  High response rates.
Lung Cancer in Never-Smokers from the Princess Margaret Cancer Centre 1 Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;
Clinical Center of the University of Sarajevo
Perioperative Complications after Neoadjuvant Chemoradiation for Locally-Advanced Esophageal Cancer: A Comparison of Platinum/5-FU and Carboplatin/Paclitaxel.
Slamon D et al. SABCS 2009;Abstract 62.
Supplemental Figure 1: FOXM1 mRNA level analysis in 48 ovarian tissues
Insert Footer or Copyright Information Here
Number of brain metastasis
BREAST CANCER IN SETTING OF HIGH HIV PREVALENCE
Uterine serous carcinoma is more aggressive than high-grade serous ovarian carcinoma: a retrospective study H. Nagano1, Y. Tachibana1, M. Kawakami1, M.
Public Health Genomics 2012;15:1–10 - DOI: /
Ari Brooks, MD Cancer Surgeon, Big Data End User
Nurdianah HF, Nizuwan A, Muhamad Yusri M
Prognostic significance of tumor subtypes in male breast cancer:
R. Michelle Sarin, MD Mentor: Jeffrey Fowler, MD
Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation Reshma Ariga, M.D., Kenneth Bloom, M.D., Vijaya.
Results of Definitive Radiotherapy in Anal Canal Carcinoma
Figure #1 Overall survival Figure #2 Disease free survival
Corresponding Author ( ):
Surgical Management of the Breast in Breast Cancer
BREAST CANCER A full classification includes histopathological type, grade, stage (TNM), receptor status, and the presence or absence of genes as determined.
Presented By Mette Van Ramshorst at 2017 ASCO Annual Meeting
Compassionate People World Class Care
THBT neoadjuvant endocrine therapy is to be used in post-menopausal breast cancer woman Antonino Grassadonia Università «G. D’Annunzio» – Chieti-Pescara.
Concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after chemoradiation: outcome and survival S.T. Heijkoop1,2; H.C. van.
Prognosis of younger patients in non-small cell lung cancer
Table 1 Baseline patient characteristics
Thanh Nhan Hospital MALE BREAST CANCER: CASE REPORT
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
Evaluate the results of concomitance chemoradiotherapy postoperative treatment for rectal cancer in stage II-III At K Hospital from 2012 to 2016 Speaker:
So you have been diagnosed with breast cancer! What's next?
Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients Breast Care 2016;11: DOI: / Fig. 1. Strategies.
Untch M et al. Proc SABCS 2010;Abstract P
EVALUTE THE EFFICACY OF ADJUVANT REGIMEN 3FEC- 3T IN STAGE II BREAST CANCER Hai Phong, 2017 LÊ THU HÀ, Ph.D. Nguyễn Khánh Hà, Dr.
Physical Activity and Endometrial Cancer Survival
Patients who have received chemotherapy (n=60)
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer. A meta-analysis of two randomized trials E Mitry, A Fields,
Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer  Thomas W Rice, MD, David J Adelstein, MD, Jay P Ciezki,
GOCS GRUPO ONCOLÓGICO COOPERATIVO DEL SUR
THE LANCET Oncology Volume 19, No. 1, p27–39, January 2018
Principles and Practice of Radiation Therapy
Presentation transcript:

Marcelo Calil Instituto Brasileiro de Controle do Câncer Male breast cancer: Epidemiological study in patients attended in three academic hopitals in São Paulo -Brazil Marcelo Calil Instituto Brasileiro de Controle do Câncer Instituto Brasileiro de Controle do Câncer – IBCC São Paulo - Brazil 910

Table 1: Clinical characteristics of patients INTRODUCTION: Male breast cancer is rare, accounting for approximately 1% of all cases of breast cancer. METHODS: This retrospective study assessed data from medical records of 35 male patients with invasive breast cancer diagnosed between February 2003 and April 2013, at our service Table 1: Clinical characteristics of patients Clinical characteristic Total (n=35) Median age (range) 65 (42-91) Histology Ductal carcinoma Lobular carcinoma 32 (91,4%) 22 (8,6%) Stage I II III IV 6 (17,1%) 17 (48,6%) 6(17,1%) Hormone receptor Positive Negative 31 (88,6%) 4 (11,4%) HER 2 status 3 (8,6%) Family history of cancer Yes No 10 (28,6%) 25(71,4%) Table 1: Clinical characteristics of patients

Table 2: Treatment received Male breast cancer: Epidemiological study in patients attended in three academic hopitals in São Paulo-Brazil Table 2: Treatment received Treatment Total (n=35) Surgery Yes No 31 (88,6%) 4 (11,4%) Type of surgery Mastectomy Breast conserving surgery 30 (96,8%) 1 (3,2%) Chemotherapy 25 (73,5%) 9 (26,5% Type of chemotherapy Neoadjuvant Adjuvant Paliative 1 (4%) 21( 84%) 3 (12%) Fig 1:Progresion free survival (A) and overall survival (B) Time (months) Time (months)

Male breast cancer: Epidemiological study in patients attended in three academic hopitals in São Paulo-Brazil CONCLUSION: The epidemiological and pathological features, as well as treatment, are similar to literature. The stage II was the most prevalent in our sample, different from those described in the literature. KEYWORDS: MALE, BREAST, CANCER, EPIDEMIOLOGICAL.